06
ResearchSupplements · Metabolism · Meta-analysis

Berberine: a trending supplement with a real evidence base

CEBM 1a ★★★☆☆ 3 / 5 12 RCTs, a strong design, but the samples are small and mostly Asian, so the applicability to other populations is uncertain.

Berberine is often called a "natural metformin." Unlike most fashionable supplements, it is backed by a meta-analysis of 12 RCTs and 889 participants with metabolic syndrome.

What they found

Over 3 to 5 months, berberine lowered triglycerides by 0.367 mmol/L, fasting glucose by 0.515 mmol/L, waist circumference by 3.27 cm, and LDL by 0.495 mmol/L.

12 RCTs
and 889 participants, a rare evidence base for a supplement. But the samples are small, and the populations come mostly from China, Mexico and India.
What it did not do

Berberine had no effect on "good" cholesterol (HDL) or blood pressure. So it is not a cure-all but a targeted tool that works on a few specific metabolic markers.

Why it matters

Berberine is one of the few supplements you can discuss in the language of numbers rather than marketing. At the same time, it interacts with medications and does not replace prescribed therapy.

Bottom line

The evidence exists, but it is modest. Berberine is a candidate helper in metabolic syndrome, not a substitute for lifestyle and medication.

Source: meta-analysis, 2025 (12 RCTs, 889 participants)
View on PubMed ↗
← All "Decoding the Evidence" reviews